The big financial and economic wildcard–when will there be a vaccine?
Nothing else will matter very much--not a huge drop in first and second quarter GDP that's bad enough to qualify as a recession, not even a resurgence in the rate of coronavirus infections in states and countries that dropped their social distancing restrictions too...
The re-opening rally is back on
Today is all about optimism--forget plunging oil prices, uncertain earnings, or a first quarter drop in GDP-- for an upturn in the economy as more states--Colorado is newest to climb on board--re-open parts of their economies. Today, at least, no one is worried,...
Buy-on-the-dip Dip-O-Meter update for April 27
Still waiting for a second bottom before going hog wild on buy-on-the-dip buying. Some interesting prices here, certainly, for Middleby (MIDD), HBFC (HDB), Westpac Bank (WBK), and Infineon (IFNNY0, but I'm still convinced that we'll see another dip in...
Saturday Night Quarterback says, For the week ahead expect…
... earnings drama. The week features reports from Amazon (AMZN), Apple (AAPL), Alphabet (GOOG), Facebook (FB), Microsoft (MSFT), ExxonMobil (XOM) General Electric (GE), Caterpillar (CAT), Ford (F), Tesla (TSLA), Starbucks (SBUX), McDonald's (MCD), Pfizer, and Gilead...
Trick or trend: 10 stocks young investors bought in March
Our regular (or occasional or perhaps occasionally regular) Friday series (actually running on Friday this week) Trick or Trend looks at what might (or might not) be emerging investible trends. Exclusively on JAM. This post won't run anywhere else. Ever. This comes...
Georgia re-opens with almost no testing–we’ll find out how bad that could be
Today, Governor Brian Kemp's order to re-open Georgia for business went into effect. Barbershops and nail parlors, for example, were allowed to open as long as workers and customers maintained 6-foot social distancing. Think of Kemp's order as a giant scientific...
Brazil ETF falls 8% today on double blows of political scandal and coronavirus response (or lack thereof)
As of the close on April 24, the iShares MSCI Brazil Capped ETF (EWZ) was down 7.71% today t0 $22.15. Brazil is facing an intertwined crisis as a president who has called the coronavirus pandemic a "fantasy" also struggles with a political crisis that threatens his...
Let’s hear it for stability–thank goodness, so far today is dull on the U.S. market
No big moves. No major disruptions. No threats of meltdowns. Today has been a welcome breather, a bit of stability, for  market that's had more than its share of excitement this week. So far. It's only 1:30 p.m. in New York. And we could see selling or buying before...
Texas coronavirus testing drops just as state gets set to open some of its economy
Texas reported its third-straight daily increase in the number of new coronavirus cases, with an additional 875 cases of the virus. That brought the state's total to 21,944. Another 18 people died, bringing total fatalities to 561. The increase comes as the number of...
West Pharmaceutical beats on earnings, revenue, and climbs 10.17% on April 23
West Pharmaceutical (WST) reported first quarter earnings of $1.01 a share on Thursday, April 23. That beat Wall Street estimates by 19 cents a share and was up 36% year over year. Revenue of $491 million for the quarter was up 10.8% year over year and exceeded Wall...
“Flop” in remesivir antiviral drug in Chinese trial takes starch out of stocks
The Financial Times reported that a Chinese trial for Gilead Sciences's (GILD) antiviral drug remdesivir against Covid-19 ended without meaningful conclusions on its efficacy. That was enough to reverse the gains in the Standard & Poor's 500 on the day. The index...Download Jim’s eBook for Free
